India to Algeria: Thalidomide Export Trade Route

The India to Algeria Thalidomide corridor is one of India's established pharmaceutical export routes, with 25 shipments documented worth a combined $518.2K USD. The route is dominated by BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, which alone accounts for roughly 50% of all export value, reflecting the consolidated nature of India's thalidomide manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $20.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during April–June, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 12.8%, placing it at rank #3 among India's top thalidomide export destinations globally.

On the import side, key buyers of Indian thalidomide in Algeria include PHCEDEHO , PHCEDEHOP, PHCEDEHOP PHARMACIE CENTRALE DES HOPITAUX DAREL BEIDA ALGIERS ALGIERS and 3 others. PHCEDEHO is the single largest importer with 7 shipments valued at $209.0K USD.

India's thalidomide exports to Algeria are driven primarily by a handful of large-scale manufacturers. BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED with 15 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Algeria benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $20.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as thalidomide 100 mg capsules (other) (tax inv# mh2411600638 dt: 28.03.2025) and thalidomide 100 mg gles (other) (tax inv# mh1160000622 dt: 11.03.2024), suggesting that buyers in Algeria tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, PHCEDEHO is the largest importer with 7 shipments worth $209.0K USD — representing 40% of all thalidomide imports from India on this route. A total of 6 buyers are active on this corridor.